Pharmacokinetics and pharmacodynamics of rocuronium in young adult and elderly patients undergoing elective surgery

To evaluate the impact of advanced age on rocuronium kinetic disposition in ASA I–III patients undergoing elective surgeries.

[1]  J. Bai,et al.  Literature Review of Gastrointestinal Physiology in the Elderly, in Pediatric Patients, and in Patients with Gastrointestinal Diseases. , 2016, Journal of pharmaceutical sciences.

[2]  Torin D. Shear,et al.  Residual Neuromuscular Block in the Elderly: Incidence and Clinical Implications , 2015, Anesthesiology.

[3]  M. Wiese,et al.  Alterations in drug disposition in older adults , 2015, Expert opinion on drug metabolism & toxicology.

[4]  J. Jamart,et al.  Performance of acceleromyography with a short and light TOF-tube compared with mechanomyography: A clinical comparison , 2014, European journal of anaesthesiology.

[5]  Vera Lucia Lanchote,et al.  Analysis of rocuronium in human plasma by liquid chromatography-tandem mass spectrometry with application in clinical pharmacokinetics. , 2014, Journal of pharmaceutical and biomedical analysis.

[6]  J. Proost,et al.  Renal function assessment in older adults. , 2013, British journal of clinical pharmacology.

[7]  A. Absalom,et al.  Pharmacology in the elderly and newer anaesthesia drugs. , 2011, Best practice & research. Clinical anaesthesiology.

[8]  S. Shi,et al.  Age-related changes in pharmacokinetics. , 2011, Current drug metabolism.

[9]  J. Driessen,et al.  Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. , 2010, British journal of anaesthesia.

[10]  L. Rasmussen,et al.  Should Dosing of Rocuronium in Obese Patients Be Based on Ideal or Corrected Body Weight? , 2009, Anesthesia and analgesia.

[11]  Ulrich Klotz,et al.  Pharmacokinetics and drug metabolism in the elderly , 2009, Drug metabolism reviews.

[12]  D. Le Couteur,et al.  Variability in Response to Medicines in Older People: Phenotypic and Genotypic Factors , 2009, Clinical pharmacology and therapeutics.

[13]  L. Skovgaard,et al.  Acceleromyography and mechanomyography for establishing potency of neuromuscular blocking agents: a randomized‐controlled trial , 2009, Acta anaesthesiologica Scandinavica.

[14]  F. Aşkar,et al.  The neuromuscular effects of 0.6 mg kg−1 rocuronium in elderly and young adults with or without renal failure* , 2008, European journal of anaesthesiology.

[15]  Jennifer M Butler,et al.  Free Drug Metabolic Clearance in Elderly People , 2008, Clinical pharmacokinetics.

[16]  L. Skovgaard,et al.  Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision , 2007, Acta anaesthesiologica Scandinavica.

[17]  R. Hofmockel,et al.  Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium , 2007, Anaesthesia.

[18]  T. Pellis,et al.  The Pharmacodynamic Effects of Rocuronium When Dosed According to Real Body Weight or Ideal Body Weight in Morbidly Obese Patients , 2004, Anesthesia and analgesia.

[19]  E. Lamb,et al.  Kidney function in older people: pathology, assessment and management. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[20]  F. Wuyts,et al.  Target-Controlled Infusion of Rocuronium in Infants, Children, and Adults: A Comparison of the Pharmacokinetic and Pharmacodynamic Relationship , 2003, Anesthesia and analgesia.

[21]  B. Plaud,et al.  Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[22]  O. Djurdjev,et al.  Screening for renal disease using serum creatinine: who are we missing? , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  B. Alldredge,et al.  Pharmacologic management of epilepsy in the elderly. , 2001, Journal of the American Pharmaceutical Association.

[24]  J. Proost,et al.  Urinary, biliary and faecal excretion of rocuronium in humans. , 2000, British journal of anaesthesia.

[25]  K. Rentsch,et al.  Quantification of the aminosteroidal non-depolarizing neuromuscular blocking agents rocuronium and vecuronium in plasma with liquid chromatography-tandem mass spectroscopy. , 2000, Clinical chemistry.

[26]  G. Groothuis,et al.  Polyspecific organic anion transporting polypeptides mediate hepatic uptake of amphipathic type II organic cations. , 1999, The Journal of pharmacology and experimental therapeutics.

[27]  A. Benzer,et al.  Pharmacokinetics of rocuronium bromide in obese female patients. , 1999, European journal of anaesthesiology.

[28]  P. Olinga,et al.  Characterization of the uptake of rocuronium and digoxin in human hepatocytes: carrier specificity and comparison with in vivo data. , 1998, The Journal of pharmacology and experimental therapeutics.

[29]  M. Steinfath,et al.  Clinical Pharmacokinetics of Alfentanil, Fentanyl and Sufentanil , 1996, Clinical pharmacokinetics.

[30]  K. Khuenl-Brady,et al.  Rocuronium bromide: time-course of action in underweight, normal weight, overweight and obese patients. , 1995, European journal of anaesthesiology. Supplement.

[31]  J. Wierda,et al.  Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokinetics. , 1994, Journal of clinical anesthesia.

[32]  P. Olinga,et al.  Characterization of transport in isolated human hepatocytes. A study with the bile acid taurocholic acid, the uncharged ouabain and the organic cations vecuronium and rocuronium. , 1994, Biochemical pharmacology.

[33]  O. Munck,et al.  The effects of dopamine and noradrenaline on cardiovascular function in patients with acute respiratory failure. , 1994, European Journal of Anaesthesiology.

[34]  J. A. Álvarez-Gómez,et al.  Pharmacokinetics and pharmacodynamics of rocuronium bromide in adult patients. , 1994, European journal of anaesthesiology. Supplement.

[35]  J. Proost,et al.  Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates. , 1993, Journal of chromatography.

[36]  R. Miller,et al.  The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat. , 1990, Anesthesiology.